Matthew Harrison
Stock Analyst at Morgan Stanley
(3.46)
# 962
Out of 5,115 analysts
708
Total ratings
49.65%
Success rate
4.15%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $767 → $768 | $783.71 | -2.00% | 58 | Dec 12, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $32.75 | -14.50% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $22.98 | +117.58% | 14 | Dec 12, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $147 → $151 | $125.67 | +20.16% | 43 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $176.33 | -11.53% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $849.95 | +30.60% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $25.93 | +58.12% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.38 | +189.86% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $60.16 | +62.90% | 23 | Oct 28, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $16.99 | +76.57% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $112 → $126 | $177.42 | -28.98% | 19 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.74 | +441.64% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $462.99 | -5.18% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $22.32 | -10.39% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $197.77 | +8.71% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.62 | +65.75% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.75 | +571.14% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $145.31 | +22.50% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.36 | +78.57% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $29.78 | +84.69% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.45 | +106.90% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $25.68 | -57.17% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.21 | +216.74% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $33.72 | -5.10% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.57 | +432.21% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.81 | -64.41% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.77 | -49.42% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $12.01 | -33.39% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.99 | +33.37% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.53 | +186.98% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $38.55 | +107.52% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.25 | +1,042.86% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $95.03 | +127.30% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.53 | +41.64% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.85 | +170.27% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $229.89 | -20.83% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $31.08 | -71.04% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $333.96 | -15.56% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $400.69 | -47.59% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $25.03 | +107.75% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $207.78 | -16.74% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $34.58 | +247.02% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $10.81 | +1,269.10% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $106.45 | -22.97% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $54.71 | +20.64% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $5.91 | +559.90% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $39.25 | +17.20% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.09 | +393.65% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,076.98 | -74.47% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.96 | +541.89% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $14.45 | +329.07% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.74 | -2.76% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $100.44 | -17.36% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $64.18 | -84.42% | 4 | Sep 10, 2018 |
Regeneron Pharmaceuticals
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $767 → $768
Current: $783.71
Upside: -2.00%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $32.75
Upside: -14.50%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $22.98
Upside: +117.58%
Gilead Sciences
Dec 12, 2025
Maintains: Overweight
Price Target: $147 → $151
Current: $125.67
Upside: +20.16%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $176.33
Upside: -11.53%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $849.95
Upside: +30.60%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $25.93
Upside: +58.12%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.38
Upside: +189.86%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $60.16
Upside: +62.90%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $16.99
Upside: +76.57%
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $177.42
Upside: -28.98%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.74
Upside: +441.64%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $462.99
Upside: -5.18%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $22.32
Upside: -10.39%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $197.77
Upside: +8.71%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.62
Upside: +65.75%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.75
Upside: +571.14%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $145.31
Upside: +22.50%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.36
Upside: +78.57%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $29.78
Upside: +84.69%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.45
Upside: +106.90%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $25.68
Upside: -57.17%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.21
Upside: +216.74%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $33.72
Upside: -5.10%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.57
Upside: +432.21%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.81
Upside: -64.41%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.77
Upside: -49.42%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $12.01
Upside: -33.39%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.99
Upside: +33.37%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.53
Upside: +186.98%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $38.55
Upside: +107.52%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.25
Upside: +1,042.86%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $95.03
Upside: +127.30%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.53
Upside: +41.64%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.85
Upside: +170.27%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $229.89
Upside: -20.83%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $31.08
Upside: -71.04%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $333.96
Upside: -15.56%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $400.69
Upside: -47.59%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $25.03
Upside: +107.75%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $207.78
Upside: -16.74%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $34.58
Upside: +247.02%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $10.81
Upside: +1,269.10%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $106.45
Upside: -22.97%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $54.71
Upside: +20.64%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $5.91
Upside: +559.90%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $39.25
Upside: +17.20%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.09
Upside: +393.65%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,076.98
Upside: -74.47%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.96
Upside: +541.89%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $14.45
Upside: +329.07%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.74
Upside: -2.76%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $100.44
Upside: -17.36%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $64.18
Upside: -84.42%